Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials.
Authors
Le Cesne, AOuali, M
Leahy, Michael G
Santoro, A
Hoekstra, H
Hohenberger, P
Van Coevorden, F
Rutkowski, P
Van Hoesel, R
Verweij, J
Bonvalot, S
Steward, W
Gronchi, A
Hogendoorn, P
Litiere, S
Marreaud, S
Blay, J
Van Der Graaf, W
Affiliation
Departments of Medical Oncology and Surgery, Institut Gustave Roussy, Villejuif, France.Issue Date
2014-10-06
Metadata
Show full item recordAbstract
The EORTC-STBSG coordinated two large trials of adjuvant chemotherapy(CT) in localized high grade soft tissue sarcoma(STS). Both studies failed to demonstrate any benefit on OS. The aim of the analysis of these two trials was to identify subgroups of patients who may benefit from adjuvant CT.Citation
Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials. 2014: Ann OncolJournal
Annals of OncologyDOI
10.1093/annonc/mdu460PubMed ID
25294887Type
ArticleLanguage
enISSN
1569-8041ae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdu460
Scopus Count
Collections
Related articles
- Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.
- Authors: Kasper B, Ouali M, van Glabbeke M, Blay JY, Bramwell VH, Woll PJ, Hohenberger P, Schöffski P
- Issue date: 2013 Jan
- Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.
- Authors: Squires MH, Ethun CG, Suarez-Kelly LP, Yu PY, Hughes TM, Shelby RD, Tran TB, Poultsides G, Charlson J, Gamblin TC, Tseng J, Roggin KK, Chouliaras K, Votanopoulos K, Krasnick BA, Fields RC, Pollock RE, Grignol V, Cardona K, Howard JH
- Issue date: 2020 Jan
- The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial.
- Authors: Pasquali S, Pizzamiglio S, Touati N, Litiere S, Marreaud S, Kasper B, Gelderblom H, Stacchiotti S, Judson I, Dei Tos AP, Verderio P, Casali PG, Woll PJ, Gronchi A, EORTC – Soft Tissue and Bone Sarcoma Group
- Issue date: 2019 Mar
- Treating soft tissue sarcomas with adjuvant chemotherapy.
- Authors: Patrikidou A, Domont J, Cioffi A, Le Cesne A
- Issue date: 2011 Mar
- First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials.
- Authors: Young RJ, Natukunda A, Litière S, Woll PJ, Wardelmann E, van der Graaf WT
- Issue date: 2014 Dec